New TB drug combo shows promise in phase 2 trial
NCT ID NCT07525427
First seen Apr 13, 2026 · Last updated May 22, 2026 · Updated 6 times
Summary
This study tests whether a new drug called TBD09, when used with other TB medicines, is safe and works well for adults with drug-sensitive tuberculosis. About 150 people will take part. The goal is to see how quickly the drug combination kills TB bacteria and if it causes any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
BioMedical Research Institute - Stellenbosch University @ Tygerberg Hospital
NOT_YET_RECRUITINGCape Town, Western Cape, 7505, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
-
CHRU @ Isango Lethemba
RECRUITINGBethelsdorp, Gqeberha, 6003, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
-
Clinical Research and HIV Research Unit (CHRU) @ Helen Joseph Hospital
RECRUITINGJohannesburg, Gauteng, 2092, South Africa
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Desmond Tutu Health Foundation
NOT_YET_RECRUITINGCape Town, Western Cape, 7750, South Africa
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Enhancing Care Foundation at Wentworth Hospital
RECRUITINGDurban, Bluff, 4052, South Africa
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Madibeng Centre for Research
RECRUITINGBrits, North West, 0250, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
-
ONE MRI
RECRUITINGCape Town, Western Cape, 7405, South Africa
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Setshaba Research Center
RECRUITINGPretoria, Soshangue, 0152, South Africa
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Synergy Biomedical Research Institute (SBRI)
RECRUITINGEast London, 5241, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
-
TASK Applied Science - Brookylyn Chest Hospital
RECRUITINGCape Town, Western Cape, 7405, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
-
TASK Applied Science - Eden
RECRUITINGGeorge, Central, 6529, South Africa
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Aurum Institute Tembisa
NOT_YET_RECRUITINGTembisa, Gauteng, 1736, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
-
UCT Lung Institute
RECRUITINGCape Town, Western Cape, 7700, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.